Evidence map›Paper›PMID 25064421›Full record

Trial reportJournal of substance abuse treatment2014

Is level of exposure to a 12-step facilitation therapy associated with treatment outcome?

Elizabeth A Wells, Dennis M Donovan, Dennis C Daley, Suzanne R Doyle, Greg Brigham, Sharon B Garrett, Michelle H Ingalsbe, Mary A Hatch-Maillette, Harold I Perl, Robrina Walker

Abstract readMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of substance abuse treatment, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The relationship of therapeutic alliance and treatment delivery fidelity with treatment retention in a multisite trial of twelve-step facilitation.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2015
    Trial
  2. Applying an ensemble classification tree approach to the prediction of completion of a 12-step facilitation intervention with stimulant abusers.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2014
    Trial
  3. Trial
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elizabeth A WellsSchool of Social Work, University of Washington, Seattle, WA, USA; Alcohol and Drug Abuse Institute, University of Washington, Seattle, WA, USA. Electronic address: bwells@uw.edu.
Dennis M DonovanAlcohol and Drug Abuse Institute, University of Washington, Seattle, WA, USA; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Dennis C DaleyDepartment of Psychiatry, University of Pittsburgh, and Western Psychiatric Institute and Clinic, Pittsburgh, PA, USA.
Suzanne R DoyleAlcohol and Drug Abuse Institute, University of Washington, Seattle, WA, USA.
Greg BrighamMaryhaven Inc., Columbus, OH, USA.
Sharon B GarrettAlcohol and Drug Abuse Institute, University of Washington, Seattle, WA, USA.
Michelle H IngalsbeAlcohol and Drug Abuse Institute, University of Washington, Seattle, WA, USA.
Mary A Hatch-MailletteAlcohol and Drug Abuse Institute, University of Washington, Seattle, WA, USA.
Harold I PerlNational Institute on Drug Abuse, Bethesda, MD, USA.
Robrina WalkerDepartment of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Funding

Project-004UG1DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI Steven J Shoptaw, MADHUKAR H. TRIVEDI · 2015 to 2026
$71.6M
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORKU10DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI METSCH, LISA R, SZAPOCZNIK, JOSE · 2000 to 2015
$56.9M
The National Drug Abuse Treatment Clinical Trials NetworkU10DA013045 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LING, WALTER NMN · 1999 to 2015
$52.6M
Clinical Trials Network, Ohio Valley Node U10DA013732U10DA013732 · NIDA · UNIVERSITY OF CINCINNATI · PI WINHUSEN, T JOHN · 2000 to 2015
$45.0M
Southern Consortium Node of the Clinical Trials NetworkU10DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2000 to 2015
$34.4M
CLINICAL TRIALS NETWORK: PACIFIC NORTHWEST NODEU10DA013714 · NIDA · UNIVERSITY OF WASHINGTON · PI DONOVAN, DENNIS MICHAEL, ROLL, JOHN M. · 2001 to 2015
$25.5M
Concept ProjectU10DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI TRIVEDI, MADHUKAR H. · 2005 to 2015
$22.6M
OREGON NODE - NATIONAL CLINICAL TRIALS NETWORKU10DA013036 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI MCCARTY, DENNIS · 1999 to 2010
$18.5M
CLINICAL TRIAL RESEARCH PROJECT COREU10DA020036 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DALEY, DENNIS C · 2005 to 2015
$14.1M
NIDA NIH HHS U10 DA013036NIDA NIH HHS U10 DA013714NIDA NIH HHS U10 DA013720NIDA NIH HHS U10 DA013727NIDA NIH HHS U10 DA013732NIDA NIH HHS U10 DA020024NIDA NIH HHS U10 DA020036NIDA NIH HHS U10DA13036NIDA NIH HHS U10DA13045NIDA NIH HHS U10DA13714NIDA NIH HHS U10DA13720NIDA NIH HHS U10DA13727NIDA NIH HHS U10DA13732NIDA NIH HHS U10DA20024NIDA NIH HHS U10DA20036NIDA NIH HHS UG1 DA020024
6 · The paper itself

Abstract

This study examined whether level of exposure to Stimulant Abuser Groups to Engage in 12-Step (STAGE-12), a 12-Step facilitative therapy, is related to treatment outcome. Data were from a large National Drug Abuse Treatment Clinical Trials Network (CTN) study comparing STAGE-12 combined with treatment-as-usual (TAU) to TAU alone. These analyses include only those randomized to STAGE-12 (n=234). Assessments occurred at baseline and 30, 60, 90, and 180 days following randomization. High-exposure patients (n=158; attended at least 2 of 3 individual, and 3 of 5 group, sessions), compared to those with less exposure (n=76), demonstrated: (1) higher odds of self-reported abstinence from, and lower rates of, stimulant and non-stimulant drug use; (2) lower probabilities of stimulant-positive urines; (3) more days of attending and lower odds of not attending 12-Step meetings; (4) greater likelihood of reporting no drug problems; (5) more days of duties at meetings; and (6) more types of 12-Step activities. Many of these differences declined over time, but several were still significant by the last follow-up. Treatment and research implications are discussed.

Indexed as

Patient ComplianceSelf-Help GroupsAdultDatabases, FactualFemaleHumansMaleSubstance Abuse Treatment CentersSubstance-Related DisordersSurveys and QuestionnairesTreatment OutcomeUnited States12-Step12-Step facilitationCocaineIntensive referralMethamphetamineTreatment exposure

Identifiers

PMID25064421
PMCPMC4138275

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.